2004N-0264 - Federal Measures to Mitigate BSE Risks: Considerations for Further Action
FDA Comment Number : EC12
Submitter : Dr. Marie Vodicka Date & Time: 08/20/2004 07:08:40
Organization : PhRMA
Drug Association
Category :
Issue Areas/Comments
GENERAL
GENERAL
Please see attached.